Clinical Trial Update: Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

View source ↗

Summary

A clinical trial update for a study assessing urinary exosomal biomarkers (thyroglobulin and galectin-3) to predict prognosis and monitor thyroid cancer, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Thyroid Carcinoma
• Papillary Thyroid Carcinoma
• Thyroid Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Thyroid Cancer, Papillary Thyroid Cancer | Status: ACTIVE_NOT_RECRUITING